Appropriate use of triazolam in elderly patients considering a quantitative benefit-risk assessment based on the pharmacokinetic-pharmacodynamic modeling and simulation approach supported by real-world data
Analyzing large-scale databases and existing research publications on PK/PD can practically contribute to optimizing triazolam drug therapy for the elderly in the daily clinical setting.
Authors
- Akira Okada (ORCID: https://orcid.org/0000-0001-5740-4346)
- Shoji Sera (ORCID: https://orcid.org/0009-0001-2745-5246)
- Naomi Nagai
Institutions
- Musashino University (JP)
Publication Details
- Journal
- BMC Pharmacology and Toxicology
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1186/s40360-024-00777-z
- Citations
- 5
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.93
Funders
- Musashino University
- Japan Society for the Promotion of Science